Showing results (461-470 of 5,691) with videos related to

Sort By:
Pageof 570
BMC Nephrology|June 18, 2003
r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal declineMihály Tapolyai, Satoshi Kadomatsu, Manuel Perera-Chong
BMC Nephrology|March 8, 2003
Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly populationGiorgio Coen, Santo Calabria, Silvia Lai, et al.
BMC Nephrology|November 14, 2018
The relationship between care burden and quality of life in caregivers of hemodialysis patientsHaleh Jafari, Azita Ebrahimi, Abbas Aghaei, et al.
BMC Nephrology|April 20, 2017
Epidemiology of paediatric renal stone disease: a 22-year single centre experience in the UKNaomi Issler, Stephanie Dufek, Robert Kleta, et al.
BMC Nephrology|April 20, 2017
Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney diseaseHuaiyu Wang, Li Yang, Fang Wang, et al.
BMC Nephrology|May 25, 2007
Altered collecting duct adenylyl cyclase content in collecting duct endothelin-1 knockout miceKevin A Strait, Peter K Stricklett, Donald E Kohan
BMC Nephrology|August 24, 2007
p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levelsJin-Young Park, William E Schutzer, Jessie N Lindsley, et al.
BMC Nephrology|June 28, 2008
Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysisRobert N Foley, Qiao Fan, Jiannong Liu, et al.
BMC Nephrology|April 30, 2004
Protection of rat renal vitamin E levels by ischemic-preconditioningMehri Kadkhodaee, Simin Aryamanesh, Mahdieh Faghihi, et al.
BMC Nephrology|August 10, 2005
Case-control study on analgesics and nephropathy (SAN): protocolLothar A J Heinemann, Edeltraut Garbe, Michael Lewis, et al.
Pageof 570